Investigation Overview
June 8, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Immunomedics, Inc. (NASDAQ:IMMU) shares over potential securities laws violations by Immunomedics, Inc. and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securiti...
You must register (for free) or login to view the entire investigation.